Physician

Akhil Gulati, M.D.

According to 2025 Medicare claims, Akhil Gulati, M.D. (NPI: 1346406436) practices interventional cardiology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (NPI: 1578072906; TIN: 82-2784244) and primary practice location at 48098-6375. Gulati is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Gulati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,625 traditional Medicare patients, billed 3,488 HCPCS/CPT codes, and received $185,161 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 4,967 prescription claims across 746 beneficiaries totaling $892,031 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 4 records totaling $319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,083 to $892,031. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	212	340	$26,616
2016	1,630	3,402	$230,413
2017	1,556	3,166	$196,085
2018	1,621	3,322	$228,519
2019	1,444	3,224	$206,186
2020	1,336	2,862	$192,204
2021	1,466	3,578	$241,465
2022	1,253	3,101	$210,731
2023	1,995	3,930	$193,353
2024	1,625	3,488	$185,161

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	17	38	$3,083
2016	140	564	$70,113
2017	219	1,278	$130,713
2018	319	1,648	$168,261
2019	426	2,393	$324,030
2020	465	3,092	$463,807
2021	610	3,781	$604,646
2022	665	4,324	$778,157
2023	710	4,834	$1,022,277
2024	746	4,967	$892,031

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	246	379	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	363	476	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	249	301	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	395	512	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	641	812	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	358	23,407	$432,356
Xarelto	Rivaroxaban	116	8,353	$147,199
Entresto	Sacubitril/Valsartan	93	5,403	$116,527
Repatha Sureclick	Evolocumab	75	2,448	$47,310
Praluent Pen	Alirocumab	57	2,100	$36,336

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$319	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akhil Gulati, M.D.?

Tedicare shows public-source Medicare data for Akhil Gulati, M.D. (NPI 1346406436), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akhil Gulati, M.D. have ACO affiliation data?

Akhil Gulati, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Akhil Gulati, M.D.?

Akhil Gulati, M.D. is linked to BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES (billing NPI 1578072906) in the available physician profile data.

Does Akhil Gulati, M.D. have Open Payments data?

Akhil Gulati, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.